Vidal issues non-binding guidance on Fintiv denials

23-06-2022

Vidal issues non-binding guidance on Fintiv denials

The director of the US Patent and Trademark Office, Kathi Vidal, has unveiled long-anticipated guidance for the procedures governing the discretionary denials that can be handed down by the US Patent Trial and Appeal Board (PTAB) when declining to review a patent’s validity.


Kathi Vidal, Fintiv, PTAB, USPTO, patents, Mylan, parallel litigation, big pharma

LSIPR